Professional
Added to YB: 2024-08-27
Pitch date: 2024-06-30
DGX [bullish]
Quest Diagnostics Incorporated
+52.24%
current return
Author Info
No bio for this author
Company Info
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally.
Market Cap
$22.6B
Pitch Price
$132.98
Price Target
N/A
Dividend
1.67%
EV/EBITDA
10.72
P/E
23.48
EV/Sales
2.60
Sector
Health Care Providers and Services
Category
value
FMI Funds Portfolio Holding: Quest Diagnostics Incorporated
DGX: Top US clinical lab co (24% mkt share). $85B industry, 2% of healthcare spend, influences 70% of medical decisions. Mid-single digit revenue growth, high-single digit earnings growth expected. 2-5x cheaper than hospital labs. Aging population & chronic disease drive growth. Low-double digit annual return potential at below-market valuation.
Read full article (1 min)